Lessons from medicine

September 15, 2021, 7:02AMANS NewsSteven P. Nesbit

Steven P. Nesbit
president@ans.org

I stand in awe of the pharmaceutical professionals who developed effective vaccines for COVID-19 and obtained emergency approval for their widespread use in the space of less than a year. Normally, vaccines take 10 to 15 years to develop; the previous best was four years for the mumps vaccine. The accomplishment is a testament to the ability of science and technology to work to the betterment of the human race. Does that sound familiar? The American Nuclear Society’s vision statement is “Nuclear technology is embraced for its vital contributions to improving peoples’ lives and preserving our planet.”

A tale of three states

August 11, 2021, 2:57PMANS NewsSteven P. Nesbit

Steven P. Nesbit

Stories are unfolding (or have unfolded) in three of our key states that illustrate the challenges facing the backbone of our country’s clean, reliable electricity generation infrastructure. I write, of course, about existing nuclear power plants. On the East Coast, New York is a done deal. Indian Point-3 shut down on April 30. The state authorities are banking on offshore wind to pick up the slack. They shrug off the cost and intermittency challenges associated with deploying wind power. We’ll see.

Another year, another ANS president

July 12, 2021, 3:08PMANS NewsSteven P. Nesbit

Steven P. Nesbit
president@ans.org

It’s like clockwork. In June of every year, the American Nuclear Society brings in a new elected leader for the next 12 months. I’m Steve Nesbit, the latest in a line of distinguished (and maybe a few not so distinguished) nuclear professionals who have had the honor and privilege of serving as ANS president.

This is your lucky day. Everything you ever wanted to know about me, but were afraid to ask, is in an article in the July issue of Nuclear News (page 28). Instead of plowing that ground again here, I’ll take advantage of my monthly column to cover a few other topics that are hopefully of value.